McCracken, J. T., Anagnostou, E., Arango, C., Dawson, G., McPartland, J., Murphy, D., … ISCTM/ECNP ASD Working Group, . (2021). Corrigendum to "Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. [European Neuropsychopharmacology Volume 48, July 2021, Pages 3-31]". Eur Neuropsychopharmacol, 50, 133–134. https://doi.org/10.1016/j.euroneuro.2021.07.090

McCracken, James T., Evdokia Anagnostou, Celso Arango, Geraldine Dawson, James McPartland, Declan Murphy, Gahan Pandina, Jeremy Veenstra-VanderWeele, and Jeremy ISCTM/ECNP ASD Working Group. “Corrigendum to "Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. [European Neuropsychopharmacology Volume 48, July 2021, Pages 3-31]".” Eur Neuropsychopharmacol 50 (September 2021): 133–34. https://doi.org/10.1016/j.euroneuro.2021.07.090.

McCracken JT, Anagnostou E, Arango C, Dawson G, McPartland J, Murphy D, et al. Corrigendum to "Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. [European Neuropsychopharmacology Volume 48, July 2021, Pages 3-31]". Eur Neuropsychopharmacol. 2021 Sep;50:133–4.

McCracken, James T., et al. “Corrigendum to "Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. [European Neuropsychopharmacology Volume 48, July 2021, Pages 3-31]".” Eur Neuropsychopharmacol, vol. 50, Sept. 2021, pp. 133–34. Pubmed, doi:10.1016/j.euroneuro.2021.07.090.

McCracken JT, Anagnostou E, Arango C, Dawson G, McPartland J, Murphy D, Pandina G, Veenstra-VanderWeele J, ISCTM/ECNP ASD Working Group. Corrigendum to "Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. [European Neuropsychopharmacology Volume 48, July 2021, Pages 3-31]". Eur Neuropsychopharmacol. 2021 Sep;50:133–134.